inhibits liver cancer the Wnt/β-catenin pathway.

In this paper, the mechanism of the Wnt/β-catenin pathway is introduced, and the process and principle of the experiment conducted by Huang is explained. We discussed the reliability of the conclusion that () inhibits M2 tumor-associated macrophage polarization Wnt/β-catenin pathway modulation to suppress liver cancer. We also offer suggestions for further studies of the use of in the treatment of liver cancer.